Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma-Reference-Cited by-同舟云学术

Advancements in nanotechnology for the diagnosis and treatment of multiple myeloma

Published:2020 Issue:17 Volume:8 Page:4692-4711
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Zhong Wenhao¹²³⁴⁵,Zhang Xinyu¹²³⁴⁵,Zhao Meng¹²³⁴⁵,Wu Jun¹²³⁴⁵^ORCID,Lin Dongjun¹²³⁴⁵

Affiliation:

1. Department of Hematology

2. The Seventh Affiliated Hospital

3. Sun Yat-sen University

4. Shenzhen

5. P.R. China

Abstract

Multiple myeloma (MM), known as a tumor of plasma cells, is not only refractory but also has a high relapse rate, and is the second-most common hematologic tumor after lymphoma.

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Guangdong Province Introduction of Innovative R&D Team

Science and Technology Planning Project of Shenzhen Municipality

Natural Science Foundation of Guangdong Province

Sanming Project of Medicine in Shenzhen

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00772B

Reference193 articles.

1. Pathogenesis of bone disease in multiple myeloma: from bench to bedside

2. Novel therapeutic strategies for multiple myeloma

3. Cancer statistics, 2019

4. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

5. A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia;Journal of Biomaterials Science, Polymer Edition;2023-12-19

2. Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma;Translational Cancer Research;2023-11

3. Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma;Nature Nanotechnology;2023-01-26

4. CD38-selective immuno-nano-DM1 conjugates for depleting multiple myeloma;Biomaterials Science;2023

5. BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma;Advanced Materials;2022-12-18